US Stock MarketDetailed Quotes

MRK Merck & Co

Watchlist
  • 83.010
  • -1.410-1.67%
Close Feb 14 16:00 ET
  • 83.020
  • +0.010+0.01%
Post 20:01 ET
209.99BMarket Cap12.32P/E (TTM)

Merck & Co Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
6.74%64.17B
6.79%15.62B
4.35%16.66B
7.16%16.11B
8.89%15.78B
1.40%60.12B
5.78%14.63B
6.70%15.96B
3.03%15.04B
-8.89%14.49B
Operating revenue
6.74%64.17B
6.79%15.62B
4.35%16.66B
7.16%16.11B
8.89%15.78B
1.40%60.12B
5.78%14.63B
6.70%15.96B
3.03%15.04B
-8.89%14.49B
Cost of revenue
-5.79%15.19B
-2.15%3.83B
-4.32%4.08B
-6.93%3.75B
-9.83%3.54B
-7.38%16.13B
0.80%3.91B
8.39%4.26B
-4.55%4.02B
-27.03%3.93B
Gross profit
11.33%48.98B
10.06%11.8B
7.51%12.58B
12.31%12.37B
15.85%12.24B
5.06%43.99B
7.73%10.72B
6.10%11.7B
6.11%11.01B
0.38%10.56B
Operating expense
-29.93%28.75B
-40.08%7.45B
47.49%8.59B
-61.06%6.24B
-4.15%6.48B
73.95%41.04B
92.37%12.43B
-15.80%5.83B
201.75%16.02B
37.89%6.76B
Selling and administrative expenses
2.97%10.82B
2.14%2.86B
8.42%2.73B
1.37%2.74B
0.16%2.48B
4.60%10.5B
4.35%2.8B
-0.04%2.52B
7.56%2.7B
6.72%2.48B
Research and development costs
-41.25%17.94B
-52.37%4.59B
77.26%5.86B
-73.73%3.5B
-6.64%3.99B
125.35%30.53B
155.02%9.63B
-24.82%3.31B
376.09%13.32B
65.99%4.28B
Operating profit
584.53%20.22B
353.77%4.35B
-32.15%3.98B
222.27%6.13B
51.34%5.76B
-83.84%2.95B
-149.13%-1.71B
43.01%5.87B
-198.91%-5.01B
-32.30%3.81B
Net non-operating interest income expense
16.80%-203M
-43.45%-241M
-76.92%-230M
2.98%-781M
-71.43%-240M
-19.61%-244M
25.33%-168M
44.92%-130M
Non-operating interest income
----
----
73.97%127M
-36.70%69M
-34.82%73M
132.48%365M
-26.32%70M
82.50%73M
626.67%109M
1,500.00%112M
Non-operating interest expense
----
----
4.10%330M
11.91%310M
25.21%303M
19.13%1.15B
31.91%310M
29.92%317M
15.42%277M
-0.41%242M
Other net income (expense)
-0.35%-285M
-90.32%-177M
3,962.50%309M
176.77%119M
638.46%140M
72.51%-284M
-156.02%-93M
97.49%-8M
56.34%-155M
95.05%-26M
Gain on sale of security
----
----
45.76%-64M
98.31%-4M
-84.58%60M
98.19%-30M
17.33%-62M
74.73%-118M
35.95%-237M
152.07%389M
Special income (charges)
48.41%-309M
80.00%-51M
55.56%-56M
47.02%-80M
-83.58%-123M
-77.74%-599M
-420.41%-255M
-34.04%-126M
-6.34%-151M
-26.42%-67M
-Less：Restructuring and merger&acquisition
-48.41%309M
-80.00%51M
-55.56%56M
-47.02%80M
83.58%123M
77.74%599M
420.41%255M
34.04%126M
6.34%151M
26.42%67M
Other non- operating income (expenses)
-93.04%24M
-156.25%-126M
81.78%429M
-12.88%203M
158.33%203M
-64.06%345M
-22.76%224M
-2.48%236M
48.41%233M
-226.55%-348M
Income before tax
955.37%19.94B
303.81%4.17B
-27.22%4.09B
212.58%6.01B
55.34%5.67B
-88.51%1.89B
-158.24%-2.05B
56.85%5.62B
-218.90%-5.34B
-24.91%3.65B
Income tax
85.38%2.8B
151.83%425M
6.78%929M
-14.44%545M
9.45%903M
-21.17%1.51B
-265.66%-820M
163.64%870M
18.40%637M
48.92%825M
Net income
4,444.56%17.13B
405.46%3.75B
-33.45%3.16B
191.44%5.46B
68.74%4.77B
-97.40%377M
-140.62%-1.23B
46.02%4.75B
-251.23%-5.97B
-34.41%2.83B
Net income continuous Operations
4,444.56%17.13B
405.46%3.75B
-33.45%3.16B
191.44%5.46B
68.74%4.77B
-97.40%377M
-140.62%-1.23B
46.02%4.75B
-251.23%-5.97B
-34.41%2.83B
Minority interest income
33.33%16M
2M
-20.00%4M
100.00%6M
25.00%5M
71.43%12M
0
0.00%5M
-40.00%3M
233.33%4M
Net income attributable to the parent company
4,589.59%17.12B
405.30%3.74B
-33.47%3.16B
191.30%5.46B
68.81%4.76B
-97.49%365M
-140.64%-1.23B
46.09%4.75B
-251.50%-5.98B
-34.55%2.82B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4,589.59%17.12B
405.30%3.74B
-33.47%3.16B
191.30%5.46B
68.81%4.76B
-97.49%365M
-140.64%-1.23B
46.09%4.75B
-251.50%-5.98B
-34.55%2.82B
Basic earnings per share
4,733.28%6.7666
408.26%1.4797
-33.16%1.25
191.49%2.15
69.37%1.88
-97.56%0.14
-140.34%-0.48
46.09%1.87
-250.64%-2.35
-34.71%1.11
Diluted earnings per share
4,714.29%6.74
408.26%1.4797
-33.33%1.24
191.06%2.14
68.47%1.87
-97.55%0.14
-140.68%-0.48
45.31%1.86
-251.61%-2.35
-34.71%1.11
Dividend per share
5.41%3.12
5.19%0.81
5.48%0.77
5.48%0.77
5.48%0.77
5.71%2.96
5.48%0.77
5.80%0.73
5.80%0.73
5.80%0.73
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 6.74%64.17B6.79%15.62B4.35%16.66B7.16%16.11B8.89%15.78B1.40%60.12B5.78%14.63B6.70%15.96B3.03%15.04B-8.89%14.49B
Operating revenue 6.74%64.17B6.79%15.62B4.35%16.66B7.16%16.11B8.89%15.78B1.40%60.12B5.78%14.63B6.70%15.96B3.03%15.04B-8.89%14.49B
Cost of revenue -5.79%15.19B-2.15%3.83B-4.32%4.08B-6.93%3.75B-9.83%3.54B-7.38%16.13B0.80%3.91B8.39%4.26B-4.55%4.02B-27.03%3.93B
Gross profit 11.33%48.98B10.06%11.8B7.51%12.58B12.31%12.37B15.85%12.24B5.06%43.99B7.73%10.72B6.10%11.7B6.11%11.01B0.38%10.56B
Operating expense -29.93%28.75B-40.08%7.45B47.49%8.59B-61.06%6.24B-4.15%6.48B73.95%41.04B92.37%12.43B-15.80%5.83B201.75%16.02B37.89%6.76B
Selling and administrative expenses 2.97%10.82B2.14%2.86B8.42%2.73B1.37%2.74B0.16%2.48B4.60%10.5B4.35%2.8B-0.04%2.52B7.56%2.7B6.72%2.48B
Research and development costs -41.25%17.94B-52.37%4.59B77.26%5.86B-73.73%3.5B-6.64%3.99B125.35%30.53B155.02%9.63B-24.82%3.31B376.09%13.32B65.99%4.28B
Operating profit 584.53%20.22B353.77%4.35B-32.15%3.98B222.27%6.13B51.34%5.76B-83.84%2.95B-149.13%-1.71B43.01%5.87B-198.91%-5.01B-32.30%3.81B
Net non-operating interest income expense 16.80%-203M-43.45%-241M-76.92%-230M2.98%-781M-71.43%-240M-19.61%-244M25.33%-168M44.92%-130M
Non-operating interest income --------73.97%127M-36.70%69M-34.82%73M132.48%365M-26.32%70M82.50%73M626.67%109M1,500.00%112M
Non-operating interest expense --------4.10%330M11.91%310M25.21%303M19.13%1.15B31.91%310M29.92%317M15.42%277M-0.41%242M
Other net income (expense) -0.35%-285M-90.32%-177M3,962.50%309M176.77%119M638.46%140M72.51%-284M-156.02%-93M97.49%-8M56.34%-155M95.05%-26M
Gain on sale of security --------45.76%-64M98.31%-4M-84.58%60M98.19%-30M17.33%-62M74.73%-118M35.95%-237M152.07%389M
Special income (charges) 48.41%-309M80.00%-51M55.56%-56M47.02%-80M-83.58%-123M-77.74%-599M-420.41%-255M-34.04%-126M-6.34%-151M-26.42%-67M
-Less：Restructuring and merger&acquisition -48.41%309M-80.00%51M-55.56%56M-47.02%80M83.58%123M77.74%599M420.41%255M34.04%126M6.34%151M26.42%67M
Other non- operating income (expenses) -93.04%24M-156.25%-126M81.78%429M-12.88%203M158.33%203M-64.06%345M-22.76%224M-2.48%236M48.41%233M-226.55%-348M
Income before tax 955.37%19.94B303.81%4.17B-27.22%4.09B212.58%6.01B55.34%5.67B-88.51%1.89B-158.24%-2.05B56.85%5.62B-218.90%-5.34B-24.91%3.65B
Income tax 85.38%2.8B151.83%425M6.78%929M-14.44%545M9.45%903M-21.17%1.51B-265.66%-820M163.64%870M18.40%637M48.92%825M
Net income 4,444.56%17.13B405.46%3.75B-33.45%3.16B191.44%5.46B68.74%4.77B-97.40%377M-140.62%-1.23B46.02%4.75B-251.23%-5.97B-34.41%2.83B
Net income continuous Operations 4,444.56%17.13B405.46%3.75B-33.45%3.16B191.44%5.46B68.74%4.77B-97.40%377M-140.62%-1.23B46.02%4.75B-251.23%-5.97B-34.41%2.83B
Minority interest income 33.33%16M2M-20.00%4M100.00%6M25.00%5M71.43%12M00.00%5M-40.00%3M233.33%4M
Net income attributable to the parent company 4,589.59%17.12B405.30%3.74B-33.47%3.16B191.30%5.46B68.81%4.76B-97.49%365M-140.64%-1.23B46.09%4.75B-251.50%-5.98B-34.55%2.82B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4,589.59%17.12B405.30%3.74B-33.47%3.16B191.30%5.46B68.81%4.76B-97.49%365M-140.64%-1.23B46.09%4.75B-251.50%-5.98B-34.55%2.82B
Basic earnings per share 4,733.28%6.7666408.26%1.4797-33.16%1.25191.49%2.1569.37%1.88-97.56%0.14-140.34%-0.4846.09%1.87-250.64%-2.35-34.71%1.11
Diluted earnings per share 4,714.29%6.74408.26%1.4797-33.33%1.24191.06%2.1468.47%1.87-97.55%0.14-140.68%-0.4845.31%1.86-251.61%-2.35-34.71%1.11
Dividend per share 5.41%3.125.19%0.815.48%0.775.48%0.775.48%0.775.71%2.965.48%0.775.80%0.735.80%0.735.80%0.73
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Argo Blockchain
ARBK
+5.33%
Strategy
MSTR
+3.94%
BTCS Inc
BTCS
+3.20%
Canaan
CAN
+2.29%
Bit Origin
BTOG
+1.90%

Unlock the Full List

Investment Theme ESG Investing
ESG Investing
Intraday+0.91%
Infectious Disease
Infectious Disease
Intraday-0.74%
Cancer Research
Cancer Research
Intraday-1.84%